Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)

Abstract

We present a case of erythema multiforme (EM) associated with a third (booster) dose of COVID-19 vaccination in a patient who had no cutaneous reactions to previous doses. To our knowledge, this is the first documented case of vaccine-associated EM occurring after a third/booster vaccination. Furthermore, our case emphasizes the need to remain vigilant for vaccine-associated EM in any patient recently vaccinated, regardless of whether previous vaccinations were administered without cutaneous reactions.

Keywords:

• Coronavirus
• COVID-19
• erythema multiforme
• vaccination